Major Benefits of using IMS R&D Focus

Why Use IMS R&D Focus?

Each file on Dialog has its advantages. We can see that IMS R&D Focus provides that profile Sharon wanted, and it also covers news sources so we can see what the press is saying too.

Note the major benefits of this file below:

Two types of records allow you to quickly focus on a profile of a drug or keep abreast of ongoing news on drug development all in the same database.
Compiled from a number of primary resources which include information provided directly from companies involved in research and development, interviews with key executives, official press releases, and meetings.

It also includes data from attendance at international medical and clinical symposia, research conferences and meetings; scanning of scientific proceedings; and medical and patent literature. Information is checked and validated prior to inclusion in the file.
Includes drug information: the laboratory code, nomenclature, chemical structure, and therapeutic class code.
Historically strong on international coverage.
Good source for checking licensing availability, providing contact information for follow-up.
Reports developments within companies and healthcare institutions, in addition to highlighting new drugs in research, changes in development phases, and licensing opportunities.
Indicates whether a drug is in active development, whether the document has undergone a major change, and if that change is a development phase change.

Go to the next page.

2-3